Updates

Craneware - Acquistion raises forecasts

April 2011

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Shares in Craneware, which supplies billing and auditing software to help US hospitals improve their financial performance, have jumped from our recommended price of 364p last February to 528p and superlative recent interim results should maintain this upward surge. These showed revenues rising 25% to US$16.6m, with pretax profit increasing 31% to US$4.3m. Eps rose 37% to 12.6 cents, while net cash increased 16% to US$31.2m. While debate about the shape of healthcare reform in the US continues to rage, Craneware has quietly gone about its business, with the average number of products per customer increasing from 1.5 to 1.7 whilst the number of contracts written with new and existing customers rose 33%. Importantly future revenues ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Marstons - Shares heavily over-sold

Howden Joinery - Current trading still strong

Craneware (September 2013)

Craneware (November 2012)

Craneware - Second downgrade this year (August 2012)

Craneware (March 2012)

Craneware (November 2011)

Craneware - New contract wins (September 2011)

Craneware - Another amazing share price spike (December 2010)

Craneware - Shares spike vertically by over Â£1 (October 2010)

Craneware (June 2010)

Craneware - Billing software firm enjoying quick-fire growth (February 2010)

Craneware - Billing software firm sees huge US healthcare opportunity (October 2008)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X